Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 17, 2020
Clear
SKU: GMS-2027 Category:

The global molecular diagnostics point of care (POC) market is projected to reach USD 1,893.5 million by 2025, rising 13.67 percent at CAGR over the forecast period. POC molecular diagnosis is used by healthcare professionals to identify and diagnose diseases in human samples such as urine, blood, throat swab, and stool.

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 1

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 2

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 3

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 4

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 5

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 6

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 7

Point of Care Molecular Diagnostics Market by Application (Respiratory Disease, Hospital Acquired Infection), by Technology, End User (Physician Office, ICUS), Product & Service (Kits, Software, Analyzers, Assays) - 2020 to 2025 8

1 Global Point of Care Molecular Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Point of Care Molecular Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Point of Care Molecular Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Point of Care Molecular Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Point of Care Molecular Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Point of Care Molecular Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Point of Care Molecular Diagnostics Market – By Product & Service (Market Size – &
million/billion)
8.1 Assays & Kits
8.2 Instruments/Analyzers
8.3 Services & Software

9 Global Point of Care Molecular Diagnostics Market – By Technology
9.1 RT-PCR
9.2 INAAT
9.3 Others

10 Global Point of Care Molecular Diagnostics Market – By Application
10.1 Respiratory diseases
10.2 STDs
10.3 HAIs
10.4 Oncology
10.5 Hepatitis
10.6 Other

11 Global Point of Care Molecular Diagnostics Market – By End User
11.1 Physician Offices
11.2 Hospital Emergency Departments & Intensive Care Units
11.3 Research Institutes
11.4 Other

12 Global Point of Care Molecular Diagnostics Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Point of Care Molecular Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Point of Care Molecular Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories
14.3 Danaher Corporation
14.4 Biomérieux Sa
14.5 DxNA
14.6 Atlas Genetics
14.7 Roche Diagnostics
14.8 Mesa Biotech
14.9 Quidel
14.10 Meridian Bioscience
14.11 Genepoc
14.12 Company 11 & more

15 Global Point of Care Molecular Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations